# Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

> **NCT04821375** · EARLY_PHASE1 · COMPLETED · sponsor: **Carol Fabian, MD** · enrollment: 16 (actual)

## Conditions studied

- Increased Risk for Development of Breast Cancer

## Interventions

- **DRUG:** bazedoxifene plus conjugated estrogens

## Key facts

- **NCT ID:** NCT04821375
- **Lead sponsor:** Carol Fabian, MD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-02
- **Primary completion:** 2024-05-20
- **Final completion:** 2024-12-31
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821375, "Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04821375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*